{
  "id": 12041,
  "origin_website": "Jove",
  "title": "Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis",
  "procedures": [
    "Ovarian tissue samples including ovarian cancer tissues (n = 7) and normal control ovarian tissues (n = 11) were used for this protocol. The present protocol3,4,5 is approved by the Xiangya Hospital Medical Ethics Committee of Central South University, China.\n1. Preparation of mitochondria from human ovarian cancer tissues\nPrepare 250 mL of the mitochondrial isolation buffer by mixing 210 mM mannitol, 70 mM sucrose, 100 mM potassium chloride (KCl), 50 mM Tris-HCl, 1 mM diamine tetraacetic acid (EDTA), 0.1 mM ethylene glycol bis(2-aminoethyl ether)tetraacetic acid (EGTA), 1 mM phenylmethanesulfonyl fluoride (PMSF) protease inhibitor, 2 mM sodium orthovanadate (V), and 0.2% bovine serum albumin (BSA), pH 7.4.\nPlace ~1.5 g of ovarian cancer tissues in a clean glass dish.\nAdd 2 mL of the pre-chilled mitochondrial isolation buffer to lightly wash the blood from the tissue surface 3x.\nUse clean ophthalmic scissors to fully mince the tissue into about 1 mm3 pieces, and transfer the minced tissues into a 50 mL centrifuge tube.\nAdd 13.5 mL of mitochondrial isolation buffer containing 0.2 mg/mL nagarse, and then use an electric homogenizer to homogenize (use scale 2, 10 s 6x, interval 10 s) the minced tissues (2 min, 4 °C).\nAdd another 3 mL of mitochondrial isolation buffer into the tissue homogenates and mix them well by pipetting.\nCentrifuge the prepared tissue homogenate (1,300 x g, 10 min, 4 °C). Remove the crude nuclear fraction (i.e., the pellet) and keep the supernatant.\nRecentrifuge the supernatant (10,000 x g, 10 min, 4 °C). Remove the microsomes (i.e., the supernatant) and keep the pellet.\nAdd 2 mL of mitochondrial isolation buffer and resuspend the pellet well by light pipetting.\nCentrifuge the pellet suspension (7,000 x g, 10 min, 4 °C). Discard the supernatant and keep the crude mitochondria (i.e., the pellet).",
    "Add 12 mL of 25% density gradient medium (i.e., Nycodenz) to resuspend the extracted crude mitochondria.\nMake a discontinuous density gradient by filling a tube from bottom to top with 5 mL of 34%, 8 mL of 30%, 12 mL of 25% (containing the crude mitochondria from step 1.11), 8 mL of 23%, and 3 mL of 20% density gradient medium, and centrifuge it (52,000 x g, 90 min, 4 °C).\nUse a long and blunt syringe to collect the purified mitochondria at the interface between the 25% and 30% density gradient medium into a clean tube.\nAdd mitochondrial isolation buffer into the collected mitochondria to dilute it to a three-fold volume. Centrifuge (15,000 x g, 20 min, 4 °C) and discard the supernatant.\nAdd 2 mL of mitochondrial isolation buffer to resuspend the pellet, and centrifuge (15,000 x g, 20 min, 4 °C). Discard the supernatant and keep the pellet.\nCollect the final pellet (i.e., the purified mitochondria) and store it at -20 °C.\n\tNOTE: Combine all purified mitochondria from the ovarian cancer tissue as the mitochondria sample for quantitative proteomics analysis.\n2. Preparation of mitochondria from human control ovarian tissues\nPrepare 250 mL of the mitochondrial isolation buffer as described in step 1.1.\nPlace ~1.5 g of the normal control ovarian tissues in a clean glass dish.\nAdd 2 mL of pre-chilled mitochondrial isolation buffer to lightly wash the blood from the tissue surface 3x.\nUse clean ophthalmic scissors to fully mince the tissue into about 1 mm3 pieces, and transfer the minced tissues into a 50 mL centrifuge tube.",
    "Add 8 mL of 0.05% trypsin/20 mM EDTA in phosphate-buffered saline (PBS) to the minced control tissues, and digest (30 min, room temperature), which helps to lyse the tissues and cells and release mitochondria. Then centrifuge (200 x g, 5 min). Discard the supernatant, and keep the tissues and cells.\nAdd 13.5 mL of mitochondrial isolation buffer containing 0.2 mg/mL nagarse, and then use an electric homogenizer to homogenize (use scale 2, 10 s 6x, interval 10 s) the minced tissues (2 min, 4 °C).\nAdd another 3 mL of mitochondrial isolation buffer into the tissue homogenates and mix them well by pipetting.\nCentrifuge the prepared tissue homogenate (1,300 x g, 10 min, 4°C). Remove the crude nuclear fraction (i.e., the pellet) and keep the supernatant.\nRecentrifuge the supernatant (10,000 x g, 10 min, 4°C). Remove the microsomes (i.e., the supernatant) and keep the pellet.\nAdd 2 mL of mitochondrial isolation buffer to resuspend the pellet well by light pipetting.\nCentrifuge the pellet suspension (7,000 x g, 10 min, 4 °C). Discard the supernatant and keep the crude mitochondria (i.e., the pellet).\nAdd 12 mL of 25% density gradient medium to resuspend the extracted crude mitochondria.\nMake a discontinuous density gradient by filling a tube from bottom to top with 8 mL of 38%, 5 mL of 34%, 8 mL of 30%, 12 mL of 25% (containing the crude mitochondria from step 2.12), 8 mL of 23%, and 3 mL of 20% density gradient medium, and centrifuge it (52,000 x g, 90 min, 4 °C).\nUse a long and blunt syringe to collect the purified mitochondria in the range from the interface between 25% and 30% to the interface between 34% and 38% into a clean tube.",
    "Add mitochondrial isolation buffer into the collected mitochondria to dilute it to a three-fold volume. Centrifuge (15,000 x g, 20 min, 4 °C) and discard the supernatant.\nAdd 2 mL of mitochondrial isolation buffer to resuspend the pellet, and centrifuge it (15,000 x g, 20 min, 4 °C). Discard the supernatant and keep the pellet.\nCollect the final pellet (i.e., the purified mitochondria) and store it at -20 °C.\n\tNOTE: Combine all purified mitochondria from the control ovarian tissue as the mitochondrial samples for quantitative proteomics analysis.\n3. Verification of the quality of purified tissue mitochondrial samples\nTake a tube of purified mitochondrial samples (i.e., the pellets from the ovarian cancer tissues from step 1.16 and the control ovarian tissues from step 2.17) for verification with electron microscopy (EM).\n\tNOTE: The detailed protocol was described previously15,16.\nPrepare the mitochondrial protein extraction buffer by mixing 8 M urea, 2 M thiourea, 40 mM Tris, 1 mM EDTA, 130 mM dithiothreitol (DTT), and 4% (w:v) 3-((3-cholamidopropyl) dimethylammonio)-1-propanesulfonate (CHAPS). Adjust the pH to 8.52.\nTake a tube of purified mitochondrial samples (i.e., the pellets from the ovarian cancer tissues in step 1.16 and the control ovarian tissues in step 2.17) and add mitochondrial protein extraction buffer (mitochondrial samples to protein extraction buffer, 1:5) to resuspend the pellet. Freeze the samples in liquid nitrogen 3x and store at room temperature for 2 h.\nCentrifuge at 12,000 x g, 30 min, 4 °C, collect the supernatant (i.e., the extracted mitochondrial protein sample), and measure the protein content with a bicinchoninic acid (BCA) protein assay kit.",
    "Prepare 50 mL of 1.5 M Tris-HCl (pH 8.8) by mixing 9.08 g of Tris and 40 mL of ddH2O, adjusting the pH to 8.8 using HCl, and adding ddH2O to a final volume of 50 mL. Store at 4 °C.\nPrepare 50 mL of 1 M Tris-HCl (pH 6.8) by mixing 6.06 g of Tris and 40 mL of ddH2O, adjusting the pH to 6.8 using HCl, and adding ddH2O to a final volume of 50 mL. Store at 4 °C.\nPrepare 100 mL of 30% acrylamide-bis solution by mixing 29 g of acrylamide, 1 g of bis-acrylamide, and 80 mL of ddH2O, and adding ddH2O to a final volume of 100 mL. Store it in a brown bottle at 4 °C.\nPrepare 1,000 mL of 10x tris-glycine electrophoresis buffer by mixing 29 g of glycine, 58 g of Tris, 3.7 g of sodium dodecyl sulfate (SDS), and 800 mL of ddH2O, and then adding ddH2O to a final volume of 1,000 mL.\nPrepare 10 mL of loading buffer by mixing 2 mL of glycerin, 0.02 g of bromophenol blue, 0.4 g of SDS, 2 mL of Tris-HCl pH 6.8, and 7 mL of ddH2O, and then adding ddH2O to a final volume of 10 mL.\nPrepare 10 mL of 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) resolving gel by mixing 4 mL of ddH2O, 3.3 mL of 30% acrylamide-Bis solution, 2.5 mL of 1.5 M Tris-HCl (pH 8.8), 0.1 mL of 10% SDS, 0.1 mL of 10% ammonium persulfate, and 0.004 mL of tetramethylethylenediamine (TEMED). Pour the SDS-PAGE resolving gel solution into the plate between the glass plates to the level of the bottom of the comb. Add 2 mL of isopropyl alcohol onto the top. Leave for 30 min.",
    "Remove the isopropyl alcohol and wash the top with ddH2O 3x. Pour the 5% concentration gel solution containing 4.1 mL of ddH2O, 1.0 mL of 30% acylamide-bis solution, 0.75 mL of 1 M Tris-HCl (pH 6.8), 0.06 mL of 10% SDS, 0.06 mL of 10% ammonium persulfate, and 0.006 mL of TEMED. Immediately insert the comb into the concentration gel solution, leave for 30 min, and then take out the comb.\nPrepare the 1x Tris-glycine electrophoresis buffer by diluting 100 mL of 10x Tris-glycine electrophoresis buffer with 900 mL of ddH2O and pour into the electrophoretic tank.\nMix 30 µg of the mitochondrial proteins from the ovarian cancer and control ovarian tissues from step 3.4 with loading buffer to reach a final volume of 20 µL. Boil the mixture for 5 min, then separate it with the 10% SDS-PAGE resolving gel using a constant voltage of 100 V. When the bromphenol blue reaches the bottom, stop the electrophoresis.\nPrepare 1.5 L of electrophoretic transfer buffer by mixing 150 mL of 10x Tris-glycine electrophoresis buffer, 1,050 mL of ddH2O, and 300 mL of methanol.\nSoak the PVDF membrane in 100% methanol for 10 min and in electrophoretic transfer buffer for at least 5 min. Soak five sheets of filter paper in 1x elecrophoretic transfer buffer for at least 5 min.\nTake out the SDS-PAGE gel containing the proteins, and soak it in electrophoretic transfer buffer for 10 min.\nMake a transfer cassette by placing a wet sponge on the white plate, three sheets of wet filter paper, the PVDF membrane, the SDS-PAGE gel with the proteins, two sheets of wet filter paper, and the wet sponge from the bottom to top. Avoid any bubbles.",
    "Place the transfer cassette into the electrophoretic tank, pour in the electrophoretic transfer buffer, and then transfer for 2 h under a constant 200 mA current.\nPrepare 10x Tris-buffered saline (TBS) stock solution by mixing 12.114 g of Tris, 29.22 g of NaCl, and adding ddH2O to a final volume of 500 mL. Prepare 2 L of 1x TBST by mixing 200 mL of 10x TBS, 2 mL of Tween-20, and 1,798 mL of ddH2O. Prepare 100 mL of blocking solution by mixing 100 mL of TBST and 5 g of BSA.\nAfter transfer, take out the PVDF membrane, wash lightly in TBST for 5 min, then block it in blocking solution for 1 h at room temperature.\nIncubate the PVDF membrane (4 °C overnight) with different primary antibodies specific to different subcellular organelles, including lamin B (cell nucleus; goat anti-human antibody 1: 1,000 blocking solution), flotillin-1 (cytomembrane; rabbit anti-human antibody 1:500 blocking solution), COX4I1 (mitochondrion; rabbit anti-human 1:1,000 blocking solution), GM130 (Golgi apparatus; mouse anti-human antibody 1:1,000 blocking solution), catalase (peroxisome; rabbit anti-human antibody 1:1,000 blocking solution), and cathepsin B (lysosome; rabbit anti-human antibody 1:1,000 blocking solution). Lightly wash in TBST for 5 min 3x.\nIncubate the PVDF membrane for 1 h at room temperature with the corresponding secondary antibodies (rabbit anti-goat, goat anti-rabbit, or goat anti-mouse). Lightly wash in TBST for 5 min 3x. Visualize it with electrochemiluminescence (ECL).\n4. iTRAQ-SCX-LC-MS/MS analysis\nNOTE: The detailed procedures for section 4 refer to the iTRAQ instructions (Table of Materials).\nAdd SDT buffer (4% SDS, 100 mM Tris-HCl pH 7.6, and 100 mM DTT) to the purified mitochondrial samples (i.e., the pellets from the ovarian cancer tissues from step 1.16 and the control ovarian tissues from step 2.17). Vortex the sample until there is no visible precipitate.",
    "NOTE: The mitochondrial sample to SDT buffer ratio should be 1:5.\nBoil the SDT-treated sample for 5 min, cool down the sample on ice, and then centrifuge (2,000 x g, 2 min).\nCollect the supernatant as the extracted mitochondrial protein samples and measure the protein content with a BCA protein assay kit.\nTake SDT-extracted mitochondrial proteins (200 µg of each sample) for reduction, alkylation, digestion with trypsin, desalination, and lyophilization3,4. Do three replicates for each sample.\nTreat the tryptic peptides (100 µg of each sample) from step 4.4 with 100 mM tetraethyl ammonium bromide solution (pH 8.5), and label the tryptic peptides with one of the 6-plex iTRAQ reagents according to its instructions3,4. Label each sample 3x.\nMix equally 6 labeled tryptic peptide samples (three from ovarian cancer tissues and three from control ovarian tissues), and dry with a vacuum concentrator.\nFractionate the mixed iTRAQ-labeled peptides with SCX chromatography into 60 fractions (one fraction per 1 min), then combine every two fractions as a SCX-fractionated sample (n = 30).\nSubject each SCX-fractionated sample to LC-MS/MS analysis on a mass spectrometer3,4 coupled with a nano LC system within a 60-min LC separation gradient to obtain MS/MS data.\nSearch the MS/MS data to identify proteins with the search engine (Table of Materials).\nUse the iTRAQ reporter-ion intensities to quantify each protein and determine mitochondrial differentially expressed proteins (mtDEPs) with a change of >1.5 or <-1.5 fold, and p < 0.05.\nSubscription Required. Please recommend JoVE to your librarian."
  ],
  "subjectAreas": [
    "Cancer Research"
  ],
  "bigAreas": [
    "Biomedical & Clinical Research"
  ]
}